IL10 and rheumatoid arthritis: Branched-chain FAs, which also include iso and anteiso FAs, have been found to have a beneficial anti-inflammatory role by increasing the expression of IL-10 [50], as well as 18:2 w6c and 18:3 w6c have been associated to a lower risk of rheumatoid arthritis [51] and anti-inflammatory and antithrombotic properties [52,53].